There’s big doings in the Dry Eye world! For the first time in almost 15 years there is a new medicine to treat Dry Eye Disease. Xiidra was approved by the FDA on Monday July 11th. We now have two incredible medicines to treat Dry Eye!
SkyVision Centers has been the premier Dry Eye center in Northeast Ohio for more than 10 years. In fact, SkyVision was one of the very first Dry Eye centers in all of the United States. Dr. Darrell White did some of the earliest work on how to use the first Dry Eye medicine, Restasis. We have been known as THE place to have your Dry eye treatment for a very long time.
Xiidra is a brand new, first in class medicine. It is approved to treat both the clinical signs (what your doctor sees on your exam) and the symptoms (what you experience) of Dry Eye. Xiidra is felt to work by reducing the activity of certain white blood cells that are activated on the surface of a dry eye. The studies that led to its approval show that it starts to work relatively quickly, and that it has only mild to moderate side effects. Dr. Darrell White expects that Xiidra will complement Restasis very well as both a first-line treatment, and for those people who continue to have Dry Eye symptoms despite active treatments of all kinds.
Dry Eye Disease is a chronic, progressive inflammatory disease of all of the glands that produce the component parts of our tears. It can cause many symptoms including dryness, scratchiness, burning, and tearing. After needing to wear glasses, Dry Eye Disease is the second leading cause of blurred vision in all patients. Once upon a time Dry Eye was a disease seen mostly in older people. Due to a number of factors like dietary changes and increased computer use, we are now seeing Dry Eye in people of all ages.
Last year SkyVision Centers introduced Lipiflow® to Greater Cleveland. In a few short weeks we will do the same for the new, breakthrough medicine Xiidra! Count on Dr. Darrell White and our entire SkyVision Centers team to lead the way in diagnosing and treating Dry Eye Disease!